...t trimester of pregnancy is clearly linked with an...at play a role in detoxification of cigarette smok... new study published in the journal Epidemiology ... defects. Closure of the lip occurs about 5 weeks ...at week 9. If this does not happen, a cleft lip an...
...gemeinschaft (DFG, German Research Foundation) has...y innovative and higher-risk research. They are th...e DFG,s Reinhart Koselleck Projects programme. The...euros and 1.25 million euros for their planned res...y over a five-year period. , The DFG,s Reinhart ...
...gical tit for tat may hold clues to improving the ... type 1 diabetes, according to a Medical College o...em attacks insulin-producing cells causing high bl... attack, said Dr. Rafal Pacholczyk, an immunologis...Medicine. , He just received a three-year, $495,0...
Other Biology News:First trimester smoking linked to oral clefts 2More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 2More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 3More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 4High blood sugar's impact on immune system holds clues to improving islet cell transplants 2High blood sugar's impact on immune system holds clues to improving islet cell transplants 3(Date:12/4/2009)Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts, health & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaini
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4...dium Therapeutics,(Amex: CXM ) announced positive...ed by researchers at Emory University, which demon...rs within acutely ischemic myocardium,(heart muscl...ckage of the,coronary arteries). The study employe...a heart attack or acute myocardial infarction, in ...
...ch 11 Pressure,BioSciences, Inc. (Nasdaq: PBIO )...s joined PBI,s senior executive management team as...im nearly twenty years of experience in,sales and ...ces companies.,Mr. Potter will oversee PBI,s seven...sponsible for driving the Company,s commercializat...
...11 Schering-Plough,Corporation (NYSE: SGP ) toda... Administration (FDA) of a New Drug Application (N... in the dosage strength of 20 mg of,omeprazole as ...frequent,heartburn., The NDA was submitted under ...c. of San Diego, Calif., which was signed in Octob...
Other Biology Technology:Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 2Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 3Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 4Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 5Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 6Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 7Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 2Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 3Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 4Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R) 2Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R) 3FIA-series XYZ autosampler from Ocean Optics
Mouse Matrilin-4 from R&D Systems
EDTA Solution (pH 8.0) (0.5 M) from BioVision
...eals labware. Waterproof, moisture-proof film prev...nhydrous materials. Can be folded repeatedly and t...etched lengthwise at 21C (70F), wrapping film incr...ved, film only partially returns to original lengt...
Biology Products: